Earnings FeedTerminal

⌘K

Home/Insiders/Gibson Christopher

GC

SEC Insider//CIK 0001856369

Gibson Christopher

CIK 00018563691 companySALT LAKE CITY, UT

Transactions

8

Companies

1

Filings

1

CIK

0001856369

Recent Transactions

8 trades

Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-12-04+60,000→ 973,839 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-12-04$4.63/sh−40,000→ 933,839 total
Gift
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-12-04−20,000→ 913,839 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2025-12-04−60,000→ 4,763,334 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-12-04+60,000→ 973,839 total
Sale
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-12-04$4.63/sh−40,000→ 933,839 total
Gift
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2025-12-04−20,000→ 913,839 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Class B Common Stock
2025-12-04−60,000→ 4,763,334 total

Companies

1

RECURSION PHARMACEUTICALS, INC.
Director, Chief Executive Officer
$RXRX

Recent Filings

1

4
Gibson Christopher
Dec 5, 2025

Address

C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET

SALT LAKE CITY, UT, 84101

View on SEC.gov